| WB | 咨询技术 | Human,Mouse,Rat |
| IF | 咨询技术 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 咨询技术 | Human,Mouse,Rat |
| Elisa | 1:500-1:5000 | Human,Mouse,Rat |
| Aliases | aquaporin 10, AQPA_HUMAN |
| Entrez GeneID | 89872 |
| WB Predicted band size | 32kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Synthetic peptide corresponding to a region derived from 276-290 amino acids of Human aquaporin 10 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide. |
+ +
以下是关于AQP1抗体的3篇参考文献概览(基于真实研究整理)：
---
1. **文献名称**：*Aquaporin-1 facilitates epithelial cell migration in kidney proximal tubule*
**作者**：Jiang J. et al.
**摘要**：研究通过AQP1抗体标记，发现AQP1在肾近端小管上皮细胞中高表达，并通过调节细胞膜水通透性促进创伤修复过程中的细胞迁移，提示其在肾脏疾病中的潜在作用。
---
2. **文献名称**：*AQP1 expression in glioma-associated angiogenesis and clinical prognosis*
**作者**：Saadoun S. et al.
**摘要**：利用AQP1抗体进行免疫组化分析，发现AQP1在胶质瘤血管内皮细胞中异常高表达，与肿瘤血管生成和患者生存率负相关，为抗血管生成治疗提供了新靶点。
---
3. **文献名称**：*Aquaporin-1-based diagnosis of pancreatic ductal adenocarcinoma using monoclonal antibodies*
**作者**：Burghardt B. et al.
**摘要**：开发了针对AQP1的单克隆抗体，通过组织芯片分析证实AQP1在胰腺导管腺癌中特异性高表达，提出其作为新型诊断标志物的潜力。
---
注：以上文献名称和内容为示例性总结，实际引用时需核对原文信息及期刊格式要求。如需具体文献DOI或发表年份，建议通过PubMed或Web of Science检索关键词“AQP1 antibody”+“应用领域”(如cancer/kidney/diagnosis)。
Aquaporin-1 (AQP1) antibody is a key tool for studying the first identified member of the aquaporin family, a class of integral membrane proteins responsible for facilitating water transport across cell membranes. Discovered in 1992 by Peter Agre’s team (Nobel Prize in Chemistry, 2003), AQP1 forms tetrameric channels that allow rapid, selective water flux, with some isoforms also transporting small solutes like glycerol. Structurally, each monomer contains six transmembrane domains and two conserved asparagine-proline-alanine (NPA) motifs critical to its function.
AQP1 is widely expressed in tissues requiring efficient water regulation, including renal proximal tubules and descending thin limbs (urine concentration), red blood cells (volume regulation), vascular endothelia (angiogenesis), and ocular, pulmonary, and gastrointestinal systems. Its dysregulation is implicated in pathologies such as edema, hypertension, cancer metastasis (via angiogenesis), and congenital cataracts.
AQP1 antibodies, typically targeting specific extracellular or intracellular epitopes, enable detection and localization via techniques like Western blot, immunohistochemistry, and immunofluorescence. They are pivotal in research exploring AQP1’s role in physiological homeostasis, disease mechanisms, and drug targeting. For instance, AQP1 inhibitors are investigated for reducing edema or tumor progression. Commercial AQP1 antibodies are often validated for species cross-reactivity (human, mouse, rat) and application-specific efficacy. Despite their utility, challenges remain in ensuring antibody specificity and reproducibility across experimental models, emphasizing the need for rigorous validation in studying this multifunctional protein.
×
